Department of Health and Human Services October 9, 2020 – Federal Register Recent Federal Regulation Documents
Results 1 - 7 of 7
Wockhardt Ltd., et al.; Withdrawal of Approval of Nine Abbreviated New Drug Applications
The Food and Drug Administration (FDA or Agency) is withdrawing approval of nine abbreviated new drug applications (ANDAs) from multiple applicants. The applicants notified the Agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.
Novartis Pharmaceuticals Corp., et al.; Withdrawal of Approval of 13 New Drug Applications
The Food and Drug Administration (FDA or Agency) is withdrawing approval of 13 new drug applications (NDAs) from multiple applicants. The applicants notified the Agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.
Government-Owned Inventions; Availability for Licensing; Correction
The Department of Health and Human Services, National Institutes of Health published a Notice in the Federal Register on October 1, 2020. That Notice requires a correction in the SUPPLEMENTARY INFORMATION section.
Notice of Diabetes Mellitus Interagency Coordinating Committee Meeting
The Diabetes Mellitus Interagency Coordinating Committee (DMICC) will hold a meeting on October 30, 2020. The topic for this meeting will be ``Health Literacy and Numeracy: Considerations for Equity Approaches.'' The meeting is open to the public.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
